ACAN and Alzheimer disease: While genetically targeting Acan provides valuable insights into the role of PNNs in AD, it does not account for changes in CSPG-GAG chain glycosylation and sulfation patterns observed in AD.45 Therefore, future studies should focus on elucidating the mechanisms through which changes in CSPG glycosylation and GAG sulfation patterns influence neuronal health and disease progression.